Analyst
Investor
Equibles does not estimate personal net worth.
Hemant Soni is recorded as Analyst at Investor. Hemant Soni has spoken on 2 earnings calls across 2 companies, most recently for Ind-Swift Laboratories Limited on August 17, 2026. Those appearances were for Ind-Swift Laboratories Limited and Tinna Rubber and Infrastructure Limited. The companies whose calls Hemant Soni spoke on are classified in the Healthcare and Basic Materials sectors.
“Sir, congratulations on a very good set of numbers and thank you for providing the opportunity. Sir, I just wanted to highlight one thing. I think, sir, I personally feel that 1200 crores of revenue guidelines given by you, by FI29, seems to be a little conservative.”
“Sir, thank you for providing me with the opportunity. I just wanted to check with you on the guidance which you gave for FOI 27. Did I hear it correctly, sir? Is it 670 to 700 crores for FOI 27?”
Investor
Analyst
Transcript header (unverified)
Ind-Swift Laboratories Limited
Drug Manufacturers - Specialty & Generic · Healthcare
Tinna Rubber and Infrastructure Limited
Specialty Chemicals · Basic Materials
Earnings Call for the Quarter Ended June 30, 2026
Ind-Swift Laboratories Limited
Earnings Call for the Quarter Ended June 30, 2026
Tinna Rubber and Infrastructure Limited
